IP Library › Granted Patent US 7,148,199
Granted Patent B2
US 7,148,199 · App. 10/951,150 · Granted Dec 12, 2006

Arginyl-glutamine dipeptide for treatment of pathological vascular proliferation

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,148,199
App. No.
10/951,150
Granted
Dec 12, 2006
Kind
B2
Abstract

The subject invention provides dipeptides useful in preventing pathological proliferation of blood vessels. The dipeptides of the subject invention are particularly advantageous because they are stable, bioavailable, and can be formulated in an aqueous solution.

Claims (3)

1. A method for inhibiting pathological ocular vascular proliferation in a subject in need thereof wherein the method comprises administering an effective amount, to the site or ocular vascular proliferation, of the dipeptide arginyl-glutamine, or a salt thereof.

2. The method, according to claim 1 , wherein the ocular vascular proliferation being inhibited is in a mammal.

3. The method, according to claim 1 , wherein said dipeptide, or salt thereof is administered in an aqueous formulation.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 16, 2004
From: NEU, JOSEF; GRANT, MARIA B.
To: UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC.
Reel/Frame 015381/0959 →